Published in Respir Res on October 21, 2005
Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. Respir Res (2006) 1.54
Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines. PLoS Biol (2012) 1.51
In vitro and in vivo assessment of pulmonary risk associated with exposure to combustion generated fine particles. Environ Toxicol Pharmacol (2010) 1.25
The use of a neonatal mouse model to study respiratory syncytial virus infections. Expert Rev Anti Infect Ther (2010) 1.10
IL-4Rα on CD4+ T cells plays a pathogenic role in respiratory syncytial virus reinfection in mice infected initially as neonates. J Leukoc Biol (2013) 1.01
Immunomodulation with IL-4R alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease. J Immunol (2010) 1.00
Particulate matter containing environmentally persistent free radicals and adverse infant respiratory health effects: a review. J Biochem Mol Toxicol (2012) 0.98
The immune profile associated with acute allergic asthma accelerates clearance of influenza virus. Immunol Cell Biol (2014) 0.88
Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization. Clin Exp Allergy (2008) 0.86
Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma. Respir Res (2009) 0.84
Perinatal factors in neonatal and pediatric lung diseases. Expert Rev Respir Med (2013) 0.81
Respiratory syncytial virus reverses airway hyperresponsiveness to methacholine in ovalbumin-sensitized mice. PLoS One (2012) 0.80
Sediment from hurricane katrina: potential to produce pulmonary dysfunction in mice. Int J Clin Exp Med (2008) 0.78
Respiratory syncytial virus infection reduces lung inflammation and fibrosis in mice exposed to vanadium pentoxide. Respir Res (2010) 0.78
Serotonin 5-HT₂ receptor activation prevents allergic asthma in a mouse model. Am J Physiol Lung Cell Mol Physiol (2015) 0.76
Building a better neonatal mouse model to understand infant respiratory syncytial virus disease. Respir Res (2015) 0.75
Comparison of temporal transcriptomic profiles from immature lungs of two rat strains reveals a viral response signature associated with chronic lung dysfunction. PLoS One (2014) 0.75
Neonatal respiratory syncytial virus infection has an effect on lung inflammation and the CD4(+) CD25(+) T cell subpopulation during ovalbumin sensitization in adult mice. Clin Exp Immunol (2016) 0.75
The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral Res (2017) 0.75
Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet (1999) 7.90
Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child (1986) 7.39
Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med (1997) 7.12
A critical role for eosinophils in allergic airways remodeling. Science (2004) 5.53
Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med (2000) 5.24
Defining a link with asthma in mice congenitally deficient in eosinophils. Science (2004) 5.20
Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J (Clin Res Ed) (1982) 4.36
Primary respiratory syncytial virus infection in mice. J Med Virol (1988) 3.77
Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA (2000) 3.50
Tucson Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol (2003) 3.41
Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol (1998) 2.53
Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med (1995) 2.48
Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy. Br Med J (1978) 2.35
Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur J Immunol (2001) 2.24
Outcome for acute bronchitis, bronchiolitis, and pneumonia in infancy. Arch Dis Child (1984) 2.17
Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med (2002) 2.03
Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest (1989) 1.97
Respiratory status and allergy nine to 10 years after acute bronchiolitis. Arch Dis Child (1997) 1.72
A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J Immunol (2003) 1.65
Bronchiolitis as a possible cause of wheezing in childhood: new evidence. Pediatrics (1984) 1.60
Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J Infect Dis (1998) 1.59
The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J Immunol (2005) 1.56
Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med (1997) 1.55
Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link. Am J Respir Crit Care Med (2001) 1.45
Development of neonatal Th1/Th2 function. Int Rev Immunol (2000) 1.43
Respiratory status and allergy after bronchiolitis. Arch Dis Child (1992) 1.43
Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J Immunol (2001) 1.40
Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection. J Immunol (2004) 1.38
Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma. J Immunol (2000) 1.37
Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res (1998) 1.28
Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease. J Virol (2001) 1.15
T(H)2-mediated pulmonary inflammation leads to the differential expression of ribonuclease genes by alveolar macrophages. Am J Respir Cell Mol Biol (2002) 1.12
Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges. J Infect Dis (2001) 1.12
Interactions between RSV infection, asthma, and atopy: unraveling the complexities. J Exp Med (2002) 1.11
RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life. Eur Respir J (2002) 1.09
The role of respiratory viruses in acute and chronic asthma. Clin Chest Med (2000) 1.08
Eosinophils inhibit retroviral transduction of human target cells by a ribonuclease-dependent mechanism. J Leukoc Biol (1997) 1.07
Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review. Acta Paediatr (2000) 1.03
Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease. Respir Res (2002) 0.91
Allergen recognition in the origin of asthma. Ciba Found Symp (1997) 0.81
Defining a link with asthma in mice congenitally deficient in eosinophils. Science (2004) 5.20
A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J Immunol (2003) 1.65
Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. Respir Res (2006) 1.54
Environmentally persistent free radicals amplify ultrafine particle mediated cellular oxidative stress and cytotoxicity. Part Fibre Toxicol (2009) 1.44
Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells. Toxicol In Vitro (2009) 1.39
In vitro and in vivo assessment of pulmonary risk associated with exposure to combustion generated fine particles. Environ Toxicol Pharmacol (2010) 1.25
Synergistic interactions of TLR2/6 and TLR9 induce a high level of resistance to lung infection in mice. J Immunol (2011) 1.16
Environmentally persistent free radicals induce airway hyperresponsiveness in neonatal rat lungs. Part Fibre Toxicol (2011) 1.14
T(H)2-mediated pulmonary inflammation leads to the differential expression of ribonuclease genes by alveolar macrophages. Am J Respir Cell Mol Biol (2002) 1.12
The use of a neonatal mouse model to study respiratory syncytial virus infections. Expert Rev Anti Infect Ther (2010) 1.10
Inchoate CD8+ T cell responses in neonatal mice permit influenza-induced persistent pulmonary dysfunction. J Immunol (2008) 1.02
IL-4Rα on CD4+ T cells plays a pathogenic role in respiratory syncytial virus reinfection in mice infected initially as neonates. J Leukoc Biol (2013) 1.01
Radical-containing ultrafine particulate matter initiates epithelial-to-mesenchymal transitions in airway epithelial cells. Am J Respir Cell Mol Biol (2012) 1.01
Immunomodulation with IL-4R alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease. J Immunol (2010) 1.00
Particulate matter containing environmentally persistent free radicals and adverse infant respiratory health effects: a review. J Biochem Mol Toxicol (2012) 0.98
Radical-containing particles activate dendritic cells and enhance Th17 inflammation in a mouse model of asthma. Am J Respir Cell Mol Biol (2011) 0.96
Model combustion-generated particulate matter containing persistent free radicals redox cycle to produce reactive oxygen species. Chem Res Toxicol (2013) 0.91
Maternal exposure to combustion generated PM inhibits pulmonary Th1 maturation and concomitantly enhances postnatal asthma development in offspring. Part Fibre Toxicol (2013) 0.89
Exposure to combustion generated environmentally persistent free radicals enhances severity of influenza virus infection. Part Fibre Toxicol (2014) 0.86
Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma. Respir Res (2009) 0.84
Hepatitis E antibodies in laboratory rabbits from 2 US vendors. Emerg Infect Dis (2014) 0.82
Chronic alcohol induces M2 polarization enhancing pulmonary disease caused by exposure to particulate air pollution. Alcohol Clin Exp Res (2013) 0.81
Deficiency of the two-pore-domain potassium channel TREK-1 promotes hyperoxia-induced lung injury. Crit Care Med (2014) 0.80
Toll-deficient Drosophila are resistant to infection by Pneumocystis spp.: additional evidence of specificity to mammalian hosts. Virulence (2010) 0.78
Innate IL-13 in virus-induced asthma? Nat Immunol (2011) 0.78
Sediment from hurricane katrina: potential to produce pulmonary dysfunction in mice. Int J Clin Exp Med (2008) 0.78
Serotonin 5-HT₂ receptor activation prevents allergic asthma in a mouse model. Am J Physiol Lung Cell Mol Physiol (2015) 0.76
Combustion By-Products and their Health Effects--combustion engineering and global health in the 21st century: issues and challenges. Int J Toxicol (2014) 0.75
A scalable field study protocol and rationale for passive ambient air sampling: a spatial phytosampling for leaf data collection. Environ Sci Technol (2017) 0.75